SECsense Logo

Gilead Sciences, Inc. 8-K Report: Key Corporate Updates as of August 7, 2025

$GILD
Form 8-K
Filed on: 2025-08-07
Source
Gilead Sciences, Inc. 8-K Report: Key Corporate Updates as of August 7, 2025

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Filing Type: The document is an 8-K, which is a report of unscheduled material events or corporate changes that could be of importance to shareholders or SEC.
  2. Company Information:
  • Company Name: Gilead Sciences, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK (Central Index Key): 0000882095
  • EIN (Employer Identification Number): 94-3047598
  • Address: 333 Lakeside Drive, Foster City, CA 94404
  • Phone Number: 650-574-3000
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: GILD
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Date: August 7, 2025
  • The filing represents information for the date August 7, 2025.
  1. XML Metadata: The file is structured in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting to facilitate the electronic submission of financial information.

Insights:

  • The filing is current as of August 7, 2025, indicating that it addresses events or changes that occurred up to that date.
  • An 8-K filing typically includes significant corporate events such as acquisitions, changes in management, or other important developments.
  • The company is listed on NASDAQ under the ticker GILD, suggesting it is a publicly traded company with obligations for transparency and timely reporting.
  • The information provided is essential for investors and analysts monitoring Gilead Sciences, as it could contain material information affecting the company's stock price or investor decisions.

This summary captures the essential details and potential implications of the filing for stakeholders.